Fernández-Ruiz J - Search Results

1

Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex.

Sagredo O, Ramos JA, Fernández-Ruiz J, Rodríguez ML, de Miguel R. Sagredo O, et al. Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):313-7. doi: 10.1007/s00210-005-0026-1. Epub 2005 Dec 30. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16385404

2

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Pérez-Rosado A, Manzanares J, Ramos JA, Fernández-Ruiz J. Lastres-Becker I, et al. Synapse. 2002 Apr;44(1):23-35. doi: 10.1002/syn.10054. Synapse. 2002. PMID: 11842443

3

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.

Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA. Gonzalez S, et al. Drug Alcohol Depend. 2002 Mar 1;66(1):77-84. doi: 10.1016/s0376-8716(01)00186-7. Drug Alcohol Depend. 2002. PMID: 11850139

4

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

Hansen HH, Azcoitia I, Pons S, Romero J, García-Segura LM, Ramos JA, Hansen HS, Fernández-Ruiz J. Hansen HH, et al. J Neurochem. 2002 Jul;82(1):154-8. doi: 10.1046/j.1471-4159.2002.00961.x. J Neurochem. 2002. PMID: 12091476 Free article.

5

Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons.

Gomes-da-Silva J, Pérez-Rosado A, de Miguel R, Fernández-Ruiz J, Silva MC, Tavares MA. Gomes-da-Silva J, et al. Ann N Y Acad Sci. 2002 Jun;965:68-77. Ann N Y Acad Sci. 2002. PMID: 12105086

6

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.

de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML, Ramos JA. de Lago E, et al. Eur J Pharmacol. 2002 Aug 2;449(1-2):99-103. doi: 10.1016/s0014-2999(02)01996-9. Eur J Pharmacol. 2002. PMID: 12163112

7

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernández-Ruiz J. Romero J, et al. Pharmacol Ther. 2002 Aug;95(2):137-52. doi: 10.1016/s0163-7258(02)00253-x. Pharmacol Ther. 2002. PMID: 12182961 Review.

8

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.

González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA. González S, et al. Brain Res. 2002 Nov 1;954(1):73-81. doi: 10.1016/s0006-8993(02)03344-9. Brain Res. 2002. PMID: 12393235

9

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.

Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernández-Ruiz J. Lastres-Becker I, et al. J Neurochem. 2003 Mar;84(5):1097-109. doi: 10.1046/j.1471-4159.2003.01595.x. J Neurochem. 2003. PMID: 12603833 Free article.

10

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818. J Med Chem. 2003. PMID: 12672252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters